Benefits and risks with digital dermoscopy and teledermoscopy by Dahlén Gyllencreutz, Johan
Göteborg, 2017 
SAHLGRENSKA AKADEMIN 
BENEFITS AND RISKS WITH DIGITAL DERMOSCOPY AND 
TELEDERMOSCOPY 
Akademisk avhandling 
Som för avläggande av Medicine doktorsexamen vid Sahlgrenska akademin, 
Göteborgs universitet kommer att offentligen försvaras i Hörsal Arvid Carlsson, 
Academicum, Medicinaregatan 3, den 8 december 2017, kl.13.00 
av Johan Dahlén Gyllencreutz 
Fakultetsopponent: 
Professor Rainer Hofmann-Wellenhof  
Medical University of Graz, Österrike 
Avhandlingen baseras på följande delarbeten 
I. Börve A, Dahlén Gyllencreutz J, Terstappen K, Johansson Backman E, Aldenbratt A, 
Danielsson M, Gillstedt M, Sandberg C, Paoli J. Smartphone Teledermoscopy Referrals: 
A Novel Process for Improved Triage of Skin Cancer Patients. Acta Derm Venereol 
2015; 95: 186–190. 
II. Dahlén Gyllencreutz J, Paoli J, Bjellerup M, Bucharbajeva Z, Gonzalez H, Nielsen K, 
Sandberg C, Synnerstad I, Terstappen K, Wennberg Larkö AM. Diagnostic Agreement 
and Interobserver Concordance with Teledermoscopy Referrals. J Eur Acad Dermatol 
Venereol. 2017; 31: 898-903. 
III. Dahlén Gyllencreutz J, Johansson Backman E, Terstappen K, Paoli J. Teledermoscopy 
images acquired in primary health care and hospital settings - a comparative study of 
image quality. J Eur Acad Dermatol Venereol. 2017 Aug 29. doi: 10.1111/jdv.14565. 
[Epub ahead of print] 
IV. Dahlén Gyllencreutz J, Bengtsson Boström K, Terstappen K. Does it look like 
melanoma? A pilot study of the effect of sunless tanning on dermoscopy of pigmented 
skin lesions. Br J Dermatol. 2013; 168: 867-70 
INSTITUTIONEN FÖR KLINISKA VETENSKAPER 
Göteborg, 2017 
ISBN: 978-91-628-0280-3 (Print) 978-91-628-0281-0 (PDF) http://hdl.handle.net/2077/53617 
 
BENEFITS AND RISKS WITH DIGITAL DERMOSCOPY AND 
TELEDERMOSCOPY 
Johan Dahlén Gyllencreutz 
Avdelningen för dermatologi och venereologi, Institutionen för kliniska vetenskaper, 
Sahlgrenska akademin, Göteborgs universitet, Sverige. 
Abstract 
The increasing incidence of malignant melanoma and non-melanoma skin cancer 
(NMSC) makes it necessary to optimize the management of patients with suspicious 
skin lesions, from triaging, to establishing a diagnosis and planning treatment. The 
purpose of this thesis is to investigate the use of teledermoscopy (TDS) as a way of 
achieving such an optimization, as well as to study safety aspects of digital 
dermoscopy and teledermoscopy while pointing out risks and pitfalls so that they can 
be avoided. 
In study I, smartphone TDS was compared with traditional paper referrals. The 
outcome of 772 patients referred by TDS from 20 primary health care (PHC) centres 
to two dermatology departments was compared to that of 746 patients referred without 
images. TDS provided faster management of patients with skin cancer and more 
accurate prioritisation. In study II, 80 TDS referrals and 77 paper referrals were 
evaluated by six dermatologists resulting in moderate interobserver concordance. The 
diagnostic agreement with TDS was higher for several diagnoses. It also proved easier 
to plan for surgery at the first visit and to resend referrals with clearly benign lesions. 
However, a few referrals with malignant lesions were incorrectly resent. In study III, 
two dermatologists compared the image quality of 172 dermoscopic images acquired 
in PHC with images of the same tumours obtained at the department of dermatology. 
The PHC images were of slightly lower quality but the difference was not statistically 
significant. No difference was found in the ability to correctly diagnose the lesions. In 
study IV, dermoscopic images of skin lesions, obtained before and after the use of a 
sunless tanning product containing dihydroxyacetone (DHA) were compared. For 
facial lesions, there were significantly more equivocal lesions after the use of DHA. A 
follicular pigmentation was often found, somewhat mimicking that of lentigo maligna. 
In conclusion, TDS can result in safer, more efficient management of patients with 
skin lesions of concern, earlier treatment of patients with malignant lesions and 
decreasing the need for unnecessary visits to a dermatologist. TDS images obtained in 
PHC are of similar quality to those obtained by trained dermatologists. When triaging 
TDS referrals, dermatologists should avoid resending referrals for clinically atypical 
melanocytic lesions and take into consideration the use of pigment-altering substances 
such as DHA.  
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